Home » SomaLogic, Quest Collaborate on Aptamer Applications
SomaLogic, Quest Collaborate on Aptamer Applications
May 11, 2005
SomaLogic, a clinical proteomics company, announced that it had entered a technology development agreement with Quest Diagnostics, a provider of diagnostic testing, information and services in the U.S. Under the terms of the agreement, Quest Diagnostics will develop new diagnostic tests based on SomaLogic's proprietary aptamer array platform. In addition, Quest Diagnostics has made a $15 million equity investment in SomaLogic. Additional terms of the agreements and timetables for test development were not disclosed.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/05-06-2005/0003548439&EDATE=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct